Iovance Biotherapeutics, Inc. (IOVA) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud InvestigationBusiness Wire • 05/10/25
Securities Fraud Investigation Into Iovance Biotherapeutics, Inc. (IOVA) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. CruzBusiness Wire • 05/09/25
Iovance's Q1 Earnings & Sales Miss, Stock Slides 39% on '25 View CutZacks Investment Research • 05/09/25
Iovance Biotherapeutics (IOVA) Reports Q1 Loss, Misses Revenue EstimatesZacks Investment Research • 05/08/25
Iovance Biotherapeutics to Host First Quarter 2025 Financial Results and Corporate Updates Webcast on Thursday, May 8, 2025GlobeNewsWire • 05/02/25
Iovance Biotherapeutics Announces Participation in Upcoming Scientific CongressesGlobeNewsWire • 04/23/25
Iovance Biotherapeutics Stock Is Crashing. And Here's Why Things Could Get Even Worse This Year.The Motley Fool • 04/23/25
4 Beaten-Down Stocks That Could Skyrocket by 50% to 543%, According to Wall StreetThe Motley Fool • 04/07/25
Down Nearly 80% From Its High, Is Iovance Biotherapeutics Stock Too Cheap to Pass Up?The Motley Fool • 03/12/25
Iovance's Q4: Execution Risks Mount As Infusion Growth Slows (Rating Downgrade)Seeking Alpha • 02/28/25
IOVA Q4 Earnings Beat, Stock Down on Looming Economic UncertaintyZacks Investment Research • 02/28/25
Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Fourth Quarter and Full Year 2024GlobeNewsWire • 02/27/25
Will Iovance Biotherapeutics (IOVA) Report Negative Earnings Next Week? What You Should KnowZacks Investment Research • 02/20/25